|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Kamp, F.; Hager, L.; Proebstl, Lisa; Schreiber, A.; Riebschläger, M.; Neumann, S.; Straif, M.; Schacht-Jablonowsky, Maik; Falkai, Peter 
ORCID: https://orcid.org/0000-0003-2873-8667; Pogarell, O.; Manz, K.; Soyka, M. und Koller, G.
(2020):
12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts.
In: Journal of Psychiatric Research, Bd. 129: S. 103-110
ORCID: https://orcid.org/0000-0003-2873-8667; Pogarell, O.; Manz, K.; Soyka, M. und Koller, G.
(2020):
12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts.
In: Journal of Psychiatric Research, Bd. 129: S. 103-110
Kamp, F.; Proebstl, Lisa; Hager, L.; Schreiber, A.; Riebschläger, M.; Neumann, S.; Straif, M.; Schacht-Jablonowsky, M.; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Soyka, M. und Koller, G.
(2019):
Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
In: Drug and Alcohol Dependence, Bd. 201, Nr. 1: S. 8-15
ORCID: https://orcid.org/0000-0002-7740-4076; Soyka, M. und Koller, G.
(2019):
Effectiveness of methamphetamine abuse treatment: Predictors of treatment completion and comparison of two residential treatment programs.
In: Drug and Alcohol Dependence, Bd. 201, Nr. 1: S. 8-15
Kalmanti, L.; Saußele, Susanne; Lauseker, Michael; Proetel, U.; Muller, M. C.; Hanfstein, B.; Schreiber, A.; Fabarius, A.; Pfirrmann, Markus; Schnittger, S.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Krause, S. W.; Heim, D.; Nerl, C.; Hossfeld, D. K.; Kolb, H. J.; Hochhaus, A.; Hasford, Joerg und Hehlmann, R.
(2014):
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
In: Annals of Hematology, Bd. 93, Nr. 1: S. 71-80
Hehlmann, R.; Müller, M. C.; Lauseker, Michael; Hanfstein, B.; Fabarius, A.; Schreiber, A.; Proetel, U.; Pletsch, N.; Pfirrmann, Markus; Haferlach, C.; Schnittger, S.; Einsele, H.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Ehninger, G.; Heim, D.; Heimpel, H.; Nerl, C.; Krause, S. W.; Hossfeld, D. K.; Kolb, H. J.; Hasford, Joerg; Saußele, Susanne und Hochhaus, A.
(2014):
Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV.
In: Journal of Clinical Oncology, Bd. 32, Nr. 5: S. 415-423